Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02956876Phase 3Completed
Phase 3, randomised, open-label trial in colorectal cancer (CRC) (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Number of side effects of chemotherapy for WHO grade greater than 2 at Day 7. Started Dec 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02956876.